Assessing the role of APOE in glial lipid droplet metabolism and function
Assessing the role of APOE in glial lipid droplet metabolism and function
批准号:
10645540
负责人:
Sarah Cohen
金额:
$58.56万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-15 至 2028-03-31
关键词:
AffectAgeAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAmyloidosisApolipoprotein EAreaAstrocytesBrainBrain regionCause of DeathCell DeathCellular biologyCentral Nervous SystemCodeCommunitiesCytoplasmDataData SetDatabasesDementiaDependenceDepositionDrug TargetingEducational workshopEffector CellElderlyEndoplasmic ReticulumFluorescence-Activated Cell SortingFutureGenotypeGlycolysisHomeostasisImageImmuneInflammationInflammatoryInvestigationKnockout MiceKnowledgeLate Onset Alzheimer DiseaseLipid PeroxidationLipidsLipoproteinsMetabolismMicrogliaMicroscopyMolecularMusNatural ImmunityNerve DegenerationNervous SystemNeurogliaNeuronsPathway interactionsPlayProtein IsoformsProteinsResearchResourcesRiskRoleSurfaceTestingTherapeuticUnited StatesVisualizationWorkaging brainapolipoprotein E-4brain cellcell typecytokinedisabilitygenetic risk factorin vivoinsightlaboratory experiencelipid metabolismlipid transportmouse modelnew therapeutic targetnormal agingnovelparticlepreventtrafficking
中文摘要
摘要
阿尔茨海默病(Alzheimer's disease,AD)是老年人致残和依赖性的主要原因之一
是美国第六大死亡原因。迟发性AD是最常见的形式,
超过99%的AD病例发生在65岁以后。最强的遗传风险因素发展
晚发性AD携带APOE4等位基因载脂蛋白E(APOE)主要由神经胶质细胞表达,
脑中的脂蛋白,是由星形胶质细胞和小胶质细胞分泌的脂蛋白颗粒的主要蛋白组分。
脂蛋白颗粒提供了胶质细胞和神经元之间脂质转运的双向机制。许多
最近的研究表明,神经系统脂质的不平衡与以下风险的增加有关:
发展AD。然而,APOE 4影响细胞脂质稳态的机制是
不完全理解。我们最近发现,在胶质细胞中,APOE可以运输到细胞质脂滴,
(LDs)而不是在脂蛋白颗粒上进行分泌。我们假设APOE在之前
通过直接作用于星形胶质细胞和小胶质细胞中的LD,在细胞脂质代谢中发挥未被认识的作用。
星形胶质细胞在过氧化脂质代谢中发挥重要作用,而小胶质细胞是主要的先天性
中枢神经系统的免疫效应细胞。在目标1中,我们将测试调节APOE在
星形胶质细胞对细胞脂质组成、代谢和脂质过氧化的影响。在目标2中,我们将测试效果
调节小胶质细胞中的APOE对细胞脂质组成、代谢和炎症的影响。在目标3中,
我将通过开发一个社区资源来填补一个关键的知识空白,该资源将各种LD可视化和量化。
不同基因型和年龄的小鼠的脑区和细胞类型。总之,这些研究将导致
关于APOE 4表达导致增加的细胞和分子机制的新见解
迟发性AD的风险。这项工作也可能导致识别新的药物靶点,
治疗AD。
英文摘要
ABSTRACT
Alzheimer’s disease (AD) is one of the predominant causes of disability and dependency among older
people, and the sixth leading cause of death in the United States. Late-onset AD is the most common form,
with more than 99% of AD cases occurring after age 65. The strongest genetic risk factor for developing
late-onset AD is carrying the APOE4 allele. Apolipoprotein E (APOE) is primarily expressed by glial cells in
the brain and is the major protein component of lipoprotein particles secreted by astrocytes and microglia.
Lipoprotein particles provide a bidirectional mechanism of lipid transport between glia and neurons. Many
recent studies suggest that a disequilibrium in nervous system lipids is associated with increased risk of
developing AD. However, the mechanisms by which APOE4 affects cellular lipid homeostasis are
incompletely understood. We recently discovered that in glia, APOE can traffic to cytoplasmic lipid droplets
(LDs) rather than undergoing secretion on lipoprotein particles. We hypothesize that APOE plays previously
unrecognized roles in cellular lipid metabolism by acting directly on LDs in astrocytes and microglia.
Astrocytes play important roles in metabolizing peroxidated lipids, while microglia are the primary innate
immune effector cells of the central nervous system. In Aim 1, we will test the effect of modulating APOE in
astrocytes on cellular lipid composition, metabolism, and lipid peroxidation. In Aim 2, we will test the effect
of modulating APOE in microglia on cellular lipid composition, metabolism, and inflammation. In Aim 3, we
will fill a key knowledge gap by developing a community resource visualizing and quantifying LDs in various
brain regions and cell types in mice of different genotypes and ages. Together, these studies will lead to
new insights about the cellular and molecular mechanism by which expression of APOE4 leads to increased
risk of late-onset AD. This work could also lead to the identification of novel drug targets for preventing and
treating AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular mechanisms of intra- and inter-cellular fatty acid trafficking
-
批准号:10164808
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2019
-
负责人:Sarah Cohen
-
依托单位:
Molecular mechanisms of intra- and inter-cellular fatty acid trafficking
-
批准号:10587303
-
项目类别:
-
资助金额:$11.67万
-
财政年份:2019
-
负责人:Sarah Cohen
-
依托单位:
Molecular mechanisms of intra- and inter-cellular fatty acid trafficking
-
批准号:10618338
-
项目类别:
-
资助金额:$44.7万
-
财政年份:2019
-
负责人:Sarah Cohen
-
依托单位:
Molecular mechanisms of intra- and inter-cellular fatty acid trafficking
-
批准号:9980935
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2019
-
负责人:Sarah Cohen
-
依托单位:
Molecular mechanisms of intra- and inter-cellular fatty acid trafficking
-
批准号:10404018
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2019
-
负责人:Sarah Cohen
-
依托单位:
Molecular mechanisms of intra- and inter-cellular fatty acid trafficking
-
批准号:9796895
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2019
-
负责人:Sarah Cohen
-
依托单位:
Fatty acid trafficking in astrocytes: role of mitochondrial morphology and lipid droplet dynamics
-
批准号:9658631
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2018
-
负责人:Sarah Cohen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: